Crossmark

MiRNA-3653 Is a Potential Tissue Biomarker for Increased Metastatic Risk in Pancreatic Neuroendocrine Tumours

Crossref DOI link: https://doi.org/10.1007/s12022-019-9570-y

Published Online: 2019-02-14

Published Print: 2019-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Gill, Preetjote

Kim, Edward

Chua, Terence C.

Clifton-Bligh, Roderick J.

Nahm, Christopher B.

Mittal, Anubhav

Gill, Anthony J.

Samra, Jaswinder S.
Funding

Funding for this research was provided by:

Ipsen Biopharmaceuticals (N/A)

Ipsen Biopharmaceuticals (N/A)
License Information

Text and Data Mining valid from 2019-02-14
More Information

Article History

First Online: 14 February 2019

Compliance with Ethical Standards

:

: Author Preetoje Gill declares that she has received a research grant from IPSEN which supported this study.Author Edward Kim declares that he has no conflict of interest.Author Terrence Chua declares that he has no conflict of interest.Author Roderick Clifton-Bligh has received speaker honoraria from AMGEN, EISAI and IPSEN.Author Christpher Nahm declares that he has no conflict of interest.Author Anubhav Mittal declares that he has no conflict of interest.Author Anthony Gill declares that he has no conflict of interest.Author Jaswinder Samra declares that he has received a research grant from IPSEN which supported this study.